Pilié, Patrick G <br/><br/>
Durable complete response in renal cell carcinoma clinical trials.  [electronic resource] 

 -  Lancet (London, England)  06 2019 
 - 2362-2364 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(19)30949-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Carcinoma, Renal Cell<br/>Humans<br/>Kidney Neoplasms<br/>Sunitinib